The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis
Changjun Wang, Yidong Zhou, Wei Huang, Ziyuan Chen, Hanjiang Zhu, Feng Mao, Yan Lin, Xiaohui Zhang, Songjie Shen, Ying Zhong, Xin Huang, Ge Chen, Qiang Sun · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2020
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a common disorder and a frequent side effect of endocrine therapy (ET) for breast cancer treatment.This was the first meta-analysis to investigate the impact of NAFLD on breast cancer survival.
Material and Methods:We searched Pubmed, Embase and Cochrane Central Register of Controlled Trials database for relevant studies that investigated the correlation between NAFLD and breast cancer survival.Fixed-and random-effect meta-analyses were conducted according to the heterogeneity of enrolled studies.Subgroup analyses were performed based on whether NAFLD was induced by ET administration Results: Eight cohorts from six studies including 3684 breast cancer patients were enrolled.NAFLD was significantly associated with advanced age (p < 0.001), obesity (p < 0.001), lymph node metastases (p = 0.003) and hormone receptor positivity (p < 0.001).NAFLD had no significant impact on disease free survival (DFS) [hazard ratio (HR) 1.07, 95% confidence interval (CI) = 0.64-1.77,p = 0.81] and overall survival (OS) (HR 1.29, 95% CI = 0.68-2.44,p = 0.44).In subgroup analyses, ET-associated NAFLD showed no significant impact on DFS and OS.Nonetheless, non-ET-associated NAFLD had a strong prognostic correlation with poor OS (HR 1.92, 95% CI = 1.09-3.41,p = 0.02).Conclusion: NAFLD had no significant impact on breast cancer survival.However, non-ET-associated NAFLD implied increasing death risk.Future large-scale studies are warranted to further elucidate the correlation between NAFLD and breast cancer prognosis.
Open the resolved locator · 10.7150/jca.44872
Metadata licence: OpenAlex metadata (CC0)